GPR22 and methods relating thereto

Details for Australian Patent Application No. 2006304329 (hide)

Owner Arena Pharmaceuticals, Inc.

Inventors Liaw, Chen W.

Agent FB Rice

Pub. Number AU-A-2006304329

PCT Pub. Number WO2007/047520

Priority 60/727,203 14.10.05 US

Filing date 12 October 2006

Wipo publication date 26 April 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

Event Publications

24 April 2008 PCT application entered the National Phase

  PCT publication WO2007/047520 Priority application(s): WO2007/047520

25 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006304331-Biologically excitable cells

2006304327-Polynucleotides encoding lignin biosynthetic pathway enzymes in coffee